It has been a hell of a week for modern medicine. One last bit of awesome news stems the medial journal, ACS Chemical Biology regarding a newfound dual inhibitor that if improved upon, may serve as a future treatment for Parkinson’s disease. The newly discovered inhibitor actively attacks and breaks down two proteins that are strongly associated with the development of Parkinson’s disease.
To date, scientists already work to destroy these two proteins in Parkinson’s patients with mixed results. Currently, each protein is targeted separately, but because this newfound inhibitor targets both Parkinson’s proteins, it will provide a simpler, faster way to fight the proteins related to Parkinson’s disease.
Now that scientists have identified the inhibitor, their next step is to find ways to optimize what they have found to best fight the Parkinson’s proteins. Once they establish a sufficient form of the inhibitor, tests on animals can begin.
Medical breakthroughs do not happen overnight. Instead, diseases like Parkinson’s are cured in a slow, deliberate manner. That doesn’t mean that discoveries like this one aren’t exciting; no matter how long it takes for a disease treatment to reach the market, it still must always start with one brilliant discovery like this one.